Top-line results: Vibration belt slows bone strength decline among adults with osteopenia
Click Here to Manage Email Alerts
A belt device that mechanically stimulates bones through vibration slowed the decline in bone strength among adults with osteopenia, according to top-line results announced in an industry press release.
In findings from a randomized, double-blind, sham-controlled trial, participants using the OsteoBoost vibration belt (Bone Health Technologies) more than three times per week had a decrease in the rate of decline in multiple subcomponents of bone strength, including vertebral bone density and cortical bone strength, as measured through CT scan at 1 year.
“There is a clear public health need and patient desire for a nonpharmacological intervention for bone strength.” Laura Yecies, CEO of Bone Health Technologies, said in a press release. “OsteoBoost is the first nondrug intervention to demonstrate clinical CT evidence of improved vertebral bone strength.”
As Healio previously reported, the FDA granted the belt device breakthrough device designation in December 2020. In the trial, which is being conducted in partnership with Laura D. Bilek, PhD, PT, associate dean for research at the University of Nebraska Medical Center College of Allied Health Professions, participants randomly assigned to the device used it an average of four times per week, with each session lasting 30 minutes. There was a dose response association observed, with larger strength gains found with more frequent use of the device. All endpoint measures in the trial improved in participants using the device, and no device-related serious adverse events were reported.
“The Osteoboost study demonstrates that a simple, wearable device has the potential to impact millions of women at risk for bone loss by improving bone strength,” Bilek told Healio.
The device is limited to investigational use by federal law. Submission of data for FDA review is pending.
Collapse
Click Here to Manage Email Alerts